Conferences

featured article image

Reducing the Numbers of Severe Exacerbations of Asthma With Biologics and Pharmacologic Treatments: PARTICS, MANDALA, SMART and More

Paul A Greenberger, MD

Mar 5, 2023

Read From AAAAI 2023: The Constantly Evolving Story of Food Allergiesarticle image

From AAAAI 2023: The Constantly Evolving Story of Food Allergies

Manav Singla, MD

Mar 5, 2023 Link to From AAAAI 2023: The Constantly Evolving Story of Food Allergies

Read ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advancesarticle image

ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances

Guru P Sonpavde, MD

Feb 27, 2023 Link to ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances

Read ASCO GU 2023 Highlights With Dr. Julie Gralowarticle image

ASCO GU 2023 Highlights With Dr. Julie Gralow

Julie R Gralow, MD

Feb 27, 2023 Link to ASCO GU 2023 Highlights With Dr. Julie Gralow

Read Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manelsarticle image

Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manels

JJ Haijing Zhang, MD

Feb 27, 2023 Link to Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manels

Read Medical Conferences Are an Opportunity To Nourish Mentorshipsarticle image

Medical Conferences Are an Opportunity To Nourish Mentorships

Hardeep Singh Phull, MD

Feb 6, 2023 Link to Medical Conferences Are an Opportunity To Nourish Mentorships

Read A Review of "Controversies in IBD: Shark Tank Edition"article image

A Review of "Controversies in IBD: Shark Tank Edition"

Alyssa Maria Parian, MD and 1 other

Jan 30, 2023 Link to A Review of "Controversies in IBD: Shark Tank Edition"

Read Milestones and New Research from ASCO GI 2023article image

Milestones and New Research from ASCO GI 2023

Julie R Gralow, MD

Jan 30, 2023 Link to Milestones and New Research from ASCO GI 2023

Read Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congressarticle image

Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress

James Friebe

Jan 9, 2023 Link to Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress

Read First-in-Class Agent Addresses Unmet Need in Myelomaarticle image

First-in-Class Agent Addresses Unmet Need in Myeloma

Lynne Lederman, PhD

Dec 19, 2022 Link to First-in-Class Agent Addresses Unmet Need in Myeloma

Read Questioning the Status Quo for Children with ALL at ASHarticle image

Questioning the Status Quo for Children with ALL at ASH

Lynne Lederman, PhD

Dec 19, 2022 Link to Questioning the Status Quo for Children with ALL at ASH

Read Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrencearticle image

Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence

Lynne Lederman, PhD

Dec 19, 2022 Link to Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence

Read Screening for Breast Cancer by Genetics or Imaging in Community Settingsarticle image

Screening for Breast Cancer by Genetics or Imaging in Community Settings

Lynne Lederman, PhD

Dec 19, 2022 Link to Screening for Breast Cancer by Genetics or Imaging in Community Settings

Read How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendshiparticle image

How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship

Hardeep Singh Phull, MD

Dec 19, 2022 Link to How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship

Read Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questionsarticle image

Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Stephen Douglas Smith, MD

Dec 19, 2022 Link to Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Read Benefits of Virtual Conference Attendance: ASH 2022 Editionarticle image

Benefits of Virtual Conference Attendance: ASH 2022 Edition

Samuel Kareff, MD MPH

Dec 19, 2022 Link to Benefits of Virtual Conference Attendance: ASH 2022 Edition

Read Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?article image

Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Hayder Saeed, MD

Dec 19, 2022 Link to Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Read Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamaniarticle image

Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Suzanne Baga, MA, RRT

Dec 19, 2022 Link to Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Read Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancerarticle image

Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Heather Moore, CPP, PharmD and 1 other

Dec 19, 2022 Link to Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Read Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?article image

Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Kimberly J. Van Zee, MS, MD, FACS

Dec 18, 2022 Link to Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Read HER2-Low, A Separate Entity?article image

HER2-Low, A Separate Entity?

David Rimm MD-PhD

Dec 18, 2022 Link to HER2-Low, A Separate Entity?

Read Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutationsarticle image

Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Katharine Yao, MD

Dec 18, 2022 Link to Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations